Company: NCEL
Filing Date: 2025-09-10
Form Type: 424B3
Source: 0001213900-25-086600
Chunk: 834

Company: NewcelX Ltd.
Filing Date: 2025-09-10
Form: 424B3
Chunk 834
---
-on using the below control number. Voting will be open until 11:59 p.m. (Eastern Time) September 25, 2025. CONTROL 

# VOTE BY EMAIL Mark, sign and date your proxy card and send it to vote@vstocktransfer.com. * SPECIMEN * 1 MAIN STREET ANYWHERE PA 99999-9999 * SPECIMEN * 1 MAIN STREET ANYWHERE PA 99999-9999 Please Vote, Sign, Date and Return Promptly in the Enclosed Envelope. Extraordinary Meeting of Shareholders Proxy Card - NLS Pharmaceutics Ltd. DETACH PROXY CARD HERE TO VOTE BY MAIL The Board of Directors recommends a vote “FOR” all listed Proposals. 1. Approval of the Merger Agreement on an advisory basis The board proposes to approve the Merger Agreement, that the Company has entered into on 4 November 2024 according to which it will merge with Kadimastem, in the sense of an advisory vote. 2. Par Value Reduction, Reverse split and Contribution in Kind The board proposes (i) to reduce the share capital and the participation capital by a reduction of the respective nominal values, (ii) to increase the share capital and the participation capital, (iii) to implement a reverse share split and (iv) to increase the share capital by way of a contribution in kind, in each case at the terms listed in the invitation. 3. Ordinary Share Capital Increase re Preferred Shares The board proposes to increase the share capital of the Company pursuant to the terms of the PIPE SPA, by way of an ordinary capital increase, by a maximum of CHF 30,000 (i.e., via the issuance of a maximum of 500,000 fully paid-in registered preferred shares in the Company with a nominal value of CHF 0.06 each (the “Additional B Shares”)) and to issue these Additional B Shares at the terms listed in the Invitation. 4. Reinstatement of the Capital Band The board proposes to reinstate and amend the capital band with a lower limit of the minimum possible and an upper limit of the maximum possible and amend article 3a of the articles of association as provided in the invitation. 5. Amendment of the Articles re Conditional Capital for Employee and Advisory Options The board proposes to amend the Company’s conditional capital for employee and advisory options with an upper limit of CHF 27,000 by issuing a maximum of 450,000 fully paid-in registered shares,